Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV
Open Access
- 8 July 2004
- journal article
- research article
- Published by American Physiological Society in Physiological Genomics
- Vol. 18 (2), 245-248
- https://doi.org/10.1152/physiolgenomics.00102.2004
Abstract
Using carbohydrate microarrays, we characterized the carbohydrate binding activity of SARS-CoV neutralizing antibodies elicited by an inactivated SARS-CoV vaccine. In these antibodies, we detected undesired autoantibody reactivity specific for the carbohydrate moieties of an abundant human serum glycoprotein asialo-orosomucoid (ASOR). This observation provides important clues for the selection of specific immunologic probes to examine whether SARS-CoV expresses antigenic structures that mimic the host glycan. We found that lectin PHA-L (Phaseolus vulgaris L.), which is specific for a defined complex carbohydrate of ASOR, stained the SARS-CoV-infected cells specifically and intensively. Taken together, we present immunologic evidence that a carbohydrate structure of SARS-CoV shares antigenic similarity with host glycan complex carbohydrates. The experimental approaches we applied in this study are likely applicable for the identification of immunologic targets of other viral pathogens.Keywords
This publication has 17 references indexed in Scilit:
- Caution Urged on SARS VaccinesScience, 2004
- The RHL-1 subunit of the asialoglycoprotein receptor of thyroid cells: cellular localization and its role in thyroglobulin endocytosisMolecular and Cellular Endocrinology, 2003
- Carbohydrate microarraysProteomics, 2003
- Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster RecognitionScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- A Novel Coronavirus Associated with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- Koch's postulates fulfilled for SARS virusNature, 2003
- Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cellsNature Biotechnology, 2002
- Preparation of Autologous Leukemia and Lymphoma Vaccines Expressingα-Gal EpitopesJournal of Hematotherapy & Stem Cell Research, 2001
- Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibodyVaccine, 1996